BIOMAT Database Logo BIOMAT Database Logo

[Analysis of the effectiveness of anticoagulant and fibrinolytic therapy in myocardial infarct]. 1969

I M Kheĭnonen, and G K Makeeva, and I M Kholodilina

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D005260 Female Females
D005343 Fibrinolytic Agents Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. Antithrombic Drug,Antithrombotic Agent,Antithrombotic Agents,Fibrinolytic Agent,Fibrinolytic Drug,Thrombolytic Agent,Thrombolytic Agents,Thrombolytic Drug,Antithrombic Drugs,Fibrinolytic Drugs,Thrombolytic Drugs,Agent, Antithrombotic,Agent, Fibrinolytic,Agent, Thrombolytic,Agents, Antithrombotic,Drug, Antithrombic,Drug, Fibrinolytic,Drug, Thrombolytic,Drugs, Antithrombic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000925 Anticoagulants Agents that prevent BLOOD CLOTTING. Anticoagulant Agent,Anticoagulant Drug,Anticoagulant,Anticoagulant Agents,Anticoagulant Drugs,Anticoagulation Agents,Indirect Thrombin Inhibitors,Agent, Anticoagulant,Agents, Anticoagulant,Agents, Anticoagulation,Drug, Anticoagulant,Drugs, Anticoagulant,Inhibitors, Indirect Thrombin,Thrombin Inhibitors, Indirect

Related Publications

I M Kheĭnonen, and G K Makeeva, and I M Kholodilina
[Anticoagulant and fibrinolytic therapy of myocardial infarct].
January 1973, Kardiologiia,
I M Kheĭnonen, and G K Makeeva, and I M Kholodilina
[POSSIBILITIES AND LIMITATIONS OF COMBINED FIBRINOLYTIC-ANTICOAGULANT THERAPY OF MYOCARDIAL INFARCT].
September 1963, Medizinische Klinik,
I M Kheĭnonen, and G K Makeeva, and I M Kholodilina
[On the effectiveness of anticoagulant therapy in acute myocardial infarct].
January 1968, Klinicheskaia meditsina,
I M Kheĭnonen, and G K Makeeva, and I M Kholodilina
[Evaluation of the effectiveness of anticoagulant therapy of myocardial infarct].
March 1958, Terapevticheskii arkhiv,
I M Kheĭnonen, and G K Makeeva, and I M Kholodilina
[Fibrinolytic therapy in myocardial infarct].
March 1967, Prensa medica argentina,
I M Kheĭnonen, and G K Makeeva, and I M Kholodilina
[Anticoagulant therapy and myocardial infarct].
April 1963, L'union medicale du Canada,
I M Kheĭnonen, and G K Makeeva, and I M Kholodilina
[Anticoagulant therapy in myocardial infarct].
October 1952, La Presse medicale,
I M Kheĭnonen, and G K Makeeva, and I M Kholodilina
[Anticoagulant therapy in myocardial infarct].
August 1965, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
I M Kheĭnonen, and G K Makeeva, and I M Kholodilina
[Anticoagulant therapy in myocardial infarct].
April 1965, Lakartidningen,
I M Kheĭnonen, and G K Makeeva, and I M Kholodilina
[Anticoagulant therapy of myocardial infarct].
January 1962, Duodecim; laaketieteellinen aikakauskirja,
Copied contents to your clipboard!